Abbott Targets Drug and Alcohol-Impaired Drivers in New Collaboration
Intoximeters will market its alcohol testing products along with Abbott’s SoToxa Mobile Test System – a handheld oral fluid roadside testing solution that detects recent drug use.
August 14, 2019
Abbott Laboratories has developed a portable tool to help law enforcement agencies crack down on people driving under the influence. The Abbott Park, IL-based company looks to expand the reach of the diagnostic tool – SoToxa Mobile Test System- through a marketing agreement with Intoximeters.
SoToxa is an oral fluid roadside testing solution that rapidly detects recent drug use. The device tests for marijuana, cocaine, opiates, methadone, amphetamine, and benzodiazepines. Abbott inherited the device when it acquired Alere in 2017 for $5.3 billion.
Under the agreement, St. Louis, MO-based Intoximeters will market SoToxa alongside its Alco-Sensor brand breath alcohol-testing products.
Fred Delfino, Abbott’s Senior Law Enforcement Liaison, said the alliance with Intoximeters could help get SoToxa, which has been commercially available for about three years now, in the hands of law enforcement agencies. Delfino has 28 years of experience in the substance abuse testing industry, with strong knowledge in laboratory and rapid drug testing systems.